The operating room (OR) is considered one of the main cost drivers within hospitals as well as a major source of revenue. Variability in OR time can lead to inadequate utilization of the available space. Evidence suggests that the surgeon is a major source of variability in operative times. Therefore the aim of the study was to develop a model to evaluate factors that impact operative time during robot-assisted radical prostatectomy (RARP).
INTRODUCTION AND OBJECTIVES:
The operating room (OR) is considered one of the main cost drivers within hospitals as well as a major source of revenue. Variability in OR time can lead to inadequate utilization of the available space. Evidence suggests that the surgeon is a major source of variability in operative times. Therefore the aim of the study was to develop a model to evaluate factors that impact operative time during robot-assisted radical prostatectomy (RARP).
METHODS: A retrospective study was conducted at our institution from 2005-2017 utilizing data from a prospectively maintained prostate cancer database. Our model included preoperative variables like institutional volume from four surgeons, the surgeon performing the procedure, BMI, American Society of Anesthesiologists Score, prostate weight, nerve-sparing status, extent of lymph node dissection. A binary decision tree was fit using conditional interference method to predict operative times. The variable most associated with operative time was determined using permutation tests. Data were split at the value of the variable that results in the largest difference in mean surgical time across the split. The process was repeated recursively on the resultant data.
RESULTS: 1,296 procedures were included to develop the model. The variable most strongly associated with the operative time was the surgeon performing the procedure (surgeons 2-4 were 94 minutes on average longer than surgeon 1, p<0.001). Among surgeons 2-4, the type of lymph node dissection (bilateral, unilateral or none) was most strongly associated with overall surgical time (p<0.001). Depending on whether lymph node dissection was performed, the next major predictor among this cohort was the surgeon performing the procedure. Surgeon 2 was 45 min longer than surgeons 3 and 4 (p<0.001). For surgeon 1, BMI > 30 was most strongly associated with higher surgical time (p<0.001). After BMI, the second major predictor of operative time for this lone surgeon was the type of lymph node dissection, bilateral, unilateral, or none (p<0.001).
CONCLUSIONS: Variation in operative times for RARP is largely driven by the surgeon performing the procedure. Understanding how surgeon variation effects operative times could lead to better patient flow and scheduling in the OR.
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MP60-12 NOMOGRAM WITH PREDICTORS OF BIOCHEMICAL RECURRENCE IN MARGIN POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY WITHOUT ADJUVANT RADIOTHERAPY
INTRODUCTION AND OBJECTIVES: Men with positive surgical margin (PSM) at radical prostatectomy (RP) have higher rates of biochemical recurrence (BCR). The role of adjuvant radiotherapy (ART) for patients with PSM after radical prostatectomy has been shown to prevent BCR, but overtreatment remains a significant concern. The present study, therefore, sought to identify men with PSM at higher risk for BCR after RP in the absence of ART. We developed a postoperative nomogram with these identified risk factors.
METHODS: We retrospectively reviewed 2,301 men who underwent RP for prostate cancer at our institution between 2001 and 2010. The patients who received neoadjuvant or adjuvant therapy and patients without adequate medical records were excluded. Among these patients, 977 patients with positive surgical margins were analyzed. The Kaplan-Meier method was used to estimate and compare BCR-free survival (BCRFS). Cox regression models were used to investigate predictors of BCR. Nomogram predictor variables included preoperative prostate specific antigen (PSA), pathologic T stage, RP Gleason score (GS) and tumor volume. The concordance index was used as an accuracy measure, with bootstrapping to correct for optimistic bias. Calibration plots were constructed. CONCLUSIONS: Our study demonstrated the heterogeneity of oncologic outcomes in patients with PSM. Stratifying men with PSM by prognostic factors such as preoperative PSA, pathological T stage, RP GS, and tumor volume will improve identification of those at higher risk for BCR that should be strongly considered for ART. A nomogram was developed to predict 5-year BCRFS after RP in PSM patients. This tool should be useful for determining whether to perform ART in PSM patients.
